Skip to content

Vitrectomy for diabetic macular edema

Vitrectomy for diabetic macular edema

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017519
Enrollment
Unknown
Registered
2018-08-02
Start date
2018-08-15
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic macular edema

Interventions

Group 1:internal limiting membrane peeling
Group 2:foveola nonpeeling in internal limiting membrane peeling

Sponsors

Tianjin Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients with diabetic macular edema

Exclusion criteria

Exclusion criteria: 1. patients with ocular trauma, macular degeneration, new vessels, glaucoma, pathological myopia, and other eye diseases may affect corrected vision expect age-related cataract ;or underwent previous ocular surgery (except age-related cataract surgery); 2. patients with TRD , non-clearing vitreous hemorrhage or iris neovascularization; 3. patients which is not satisfied with glycemic or blood pressure control and cardiac disease; 4. 12-month duration of follow-up; 5. pregnancy or current oral contraceptive intake; 6. usage of clopidogrel bisulfate or coumadin; 7. uncontrolled renal or liver disease.

Design outcomes

Primary

MeasureTime frame
best corrected visua acuity;central macular thickness;

Countries

China

Contacts

Public ContactYue Zhang

Tianjin Eye Hospital

zhongguol985@163.com+86 023 27313336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026